These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10814728)

  • 21. The glycoprotein P0 in peripheral gliogenesis.
    Sommer L; Suter U
    Cell Tissue Res; 1998 Apr; 292(1):11-6. PubMed ID: 9506907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sublytic terminal complement complexes decrease P0 Gene expression in Schwann cells.
    Dashiell SM; Koski CL
    J Neurochem; 1999 Dec; 73(6):2321-30. PubMed ID: 10582590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of myelin-specific gene expression. Relevance to CMT1.
    Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
    Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wnt/beta-catenin signaling is an essential and direct driver of myelin gene expression and myelinogenesis.
    Tawk M; Makoukji J; Belle M; Fonte C; Trousson A; Hawkins T; Li H; Ghandour S; Schumacher M; Massaad C
    J Neurosci; 2011 Mar; 31(10):3729-42. PubMed ID: 21389228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of P0 leads to the dysregulation of myelin gene expression and myelin morphogenesis.
    Xu W; Manichella D; Jiang H; Vallat JM; Lilien J; Baron P; Scarlato G; Kamholz J; Shy ME
    J Neurosci Res; 2000 Jun; 60(6):714-24. PubMed ID: 10861783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a positive regulatory element in the myelin-specific promoter of the PMP22 gene.
    Hai M; Bidichandani SI; Patel PI
    J Neurosci Res; 2001 Sep; 65(6):508-19. PubMed ID: 11550219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
    Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
    Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters.
    Suter U; Snipes GJ; Schoener-Scott R; Welcher AA; Pareek S; Lupski JR; Murphy RA; Shooter EM; Patel PI
    J Biol Chem; 1994 Oct; 269(41):25795-808. PubMed ID: 7929285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential regulation of Wnt/beta-catenin signaling by Liver X Receptors in Schwann cells and oligodendrocytes.
    Shackleford G; Makoukji J; Grenier J; Liere P; Meffre D; Massaad C
    Biochem Pharmacol; 2013 Jul; 86(1):106-14. PubMed ID: 23500534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexpression of PMP22 gene with MBP and P0 during de novo myelination and nerve repair.
    Kuhn G; Lie A; Wilms S; Müller HW
    Glia; 1993 Aug; 8(4):256-64. PubMed ID: 7691737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of two mRNA species indicates a dual function of peripheral myelin protein PMP22 in cell growth and myelination.
    Bosse F; Zoidl G; Wilms S; Gillen CP; Kuhn HG; Müller HW
    J Neurosci Res; 1994 Mar; 37(4):529-37. PubMed ID: 8021974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myelin basic protein gene dosage effects in the PNS.
    Smith-Slatas C; Barbarese E
    Mol Cell Neurosci; 2000 Apr; 15(4):343-54. PubMed ID: 10845771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P0 mRNA expression in cultures of Schwann cells and neurons that lack basal lamina and myelin.
    Brunden KR; Brown DT
    J Neurosci Res; 1990 Oct; 27(2):159-68. PubMed ID: 1701492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: involvement of PAC1/VPAC2 receptor-mediated activation of PI3K/Akt signaling pathways.
    Castorina A; Scuderi S; D'Amico AG; Drago F; D'Agata V
    Exp Cell Res; 2014 Mar; 322(1):108-21. PubMed ID: 24246222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of neuroactive steroids on myelin of peripheral nervous system.
    Melcangi RC; Ballabio M; Cavarretta I; Gonzalez LC; Leonelli E; Veiga S; Martini L; Magnaghi V
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):323-7. PubMed ID: 12943718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteins of peripheral myelin are associated with glycosphingolipid/cholesterol-enriched membranes.
    Hasse B; Bosse F; Müller HW
    J Neurosci Res; 2002 Jul; 69(2):227-32. PubMed ID: 12111804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of myelin gene expression in murine Schwann cells in primary culture and in a Schwann cell line.
    Nicholson SM; Gomès D; Baron-Van Evercooren A; Bruzzone R
    Ann N Y Acad Sci; 1999 Sep; 883():513-7. PubMed ID: 10586287
    [No Abstract]   [Full Text] [Related]  

  • 38. Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: possible mechanisms of action.
    Melcangi RC; Magnaghi V; Cavarretta I; Zucchi I; Bovolin P; D'Urso D; Martini L
    J Neurosci Res; 1999 May; 56(4):349-57. PubMed ID: 10340743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-beta family factors.
    Hagedorn L; Suter U; Sommer L
    Development; 1999 Sep; 126(17):3781-94. PubMed ID: 10433908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New vistas on the pathomechanism of Charcot-Marie-Tooth and related peripheral neuropathies.
    Müller HW
    Ann N Y Acad Sci; 1999 Sep; 883():152-9. PubMed ID: 10586241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.